ArticleFrontiers in immunology2026

Deep learning-based assessment of PD-L1 expression in NSCLC predicts outcome for patients treated with anti-PD-1 immunotherapy.

Morgane Peroz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.